Long-Term Impact of Delaying Combination Therapy With Adalimumab Plus Methotrexate By 2 Years in Patients With Early Rheumatoid Arthritis: Final 10-Year Results of the Premier Trial
Author(s):
Keystone, E.C.; Breedveld, F.C.; Heijde, D. van der; Landewe, R.; Florentinus, S.; Arulmani, U.; Liu, S.F.; Kupper, H.; Kavanaugh, A.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-10-31
Language
English
Is part of
Arthritis and Rheumatism (2013), Vol. 65, p. S595-S595
